Clinical Trial Update: Cisplatin, Nab-paclitaxel, Nivolumab With Radiotherapy After Resection of Non-Metastatic Muscle Invasive Bladder Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating cisplatin, nab-paclitaxel, and nivolumab with radiotherapy after resection in non-metastatic muscle-invasive bladder cancer is currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Muscle-invasive Bladder Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Nab-paclitaxel (paclitaxel protein-bound)
• nivolumab (nivolumab)

Snippet

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Conditions: Muscle-Invasive Bladder Carcinoma | Phase 2 | Status: RECRUITING